; and (B) to submit to the Secretary such strategic plan. (2) Publication The Secretary shall make publicly available on the website of the National Institutes of Health, the strategic plan received under paragraph (1) as soon as possible after receipt. The Secretary shall ensure that, in publishing such plan under the preceding sentence, the design of the study involved is not disclosed. (3) Implementation The sponsor of the clinical trial that is the subject of the strategic plan published under paragraph (2), shall, not later than 90 days after such date as may be agreed upon by the sponsor of the trial and the appropriate program officer and grants management specialist of the National Institutes of Health, implement the strategic plan. (4) Technical assistance The Secretary may provide technical assistance to a sponsor of a clinical trial, as necessary for the sponsor to meet the requirements of paragraph (3). (f) Waiver for certain clinical trials (1) In general In the case of a clinical trial that received funding through the National Institutes of Health and is ongoing as of the date of the enactment of this Act, the sponsor of such clinical trial is exempt from the requirements of (and associated penalties imposed by) this Act. (2) Report The Secretary shall include in the triennial report required to be submitted under section 403 of the Public Health Service Act ( 42 U.S.C. 283 ), a list of all clinical trials receiving funding through the National Institutes of Health that requested and received waivers under this section. (g) Study (1) In general The Comptroller General of the United States shall conduct a study that— (A) examines which actions Federal agencies have taken to address barriers to participation in federally funded clinical trials by the demographic groups specified in subsection (a)(1)